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ABSTRACT We aimed to elucidate the cell types, tissues, and pathways influenced by common variants in
systemic lupus erythematosus (SLE). We applied a nonparameter enrichment statistical approach, termed
SNPsea, in 181 single nucleotide polymorphisms (SNPs) that have been identified to be associated with the risk
of SLE through genome-wide association studies (GWAS) in Eastern Asian and Caucasian populations, to
manipulate the critical cell types, tissues, and pathways. In the two most significant cells’ findings (B lymphocytes
and CD14+ monocytes), we subjected the GWAS association evidence in the Han Chinese population to an
enrichment test of expression quantitative trait locus (QTL) sites and DNase I hypersensitivity, respectively. In both
Eastern Asian and Caucasian populations, we observed that the expression level of SLE GWAS implicated genes
was significantly elevated in xeroderma pigentosum B cells (P # 1.00 · 1026), CD14+ monocytes
(P # 2.74 · 1024) and CD19+ B cells (P # 2.00 · 1026), and plasmacytoid dendritic cells (pDCs)
(P # 9.00 · 1026). We revealed that the SLE GWAS-associated variants were more likely to reside in expression
QTL in B lymphocytes (q1/q0 = 2.15, P = 1.23 · 10244) and DNase I hypersensitivity sites (DHSs) in
CD14+ monocytes (q1/q0 = 1.41, P = 0.08). We observed the common variants affected the risk of SLE mostly
through by regulatingmultiple immune system processes and immune response signaling. This study sheds light on










Systemic lupus erythematosus (SLE) is a common autoimmune disease.
It is well characterized by the production of a variety of antinuclear
antibodies, which then result in a wide spectrum of clinical symptoms
in skin, blood, kidney, and lung(Lau et al. 2006; Olson et al. 2002).
Environmental factors and genetic predisposition both contribute to
the risk of SLE (Tsokos 2011). In recent years, the genetic basis of SLE
has been advanced remarkably, mostly through genome-wide associa-
tion studies (GWAS) in diverse populations (Remmers et al. 2007;
Cunninghame Graham et al. 2008; Graham et al. 2008; International
Consortium for Systemic Lupus Erythematosus et al. 2008; Kozyrev
et al. 2008; Hom et al. 2008;Musone et al. 2008; Nath et al. 2008; Gateva
et al. 2009; Jacob et al. 2009; Webb et al. 2009; Yang et al. 2009b, 2009a;
Chang et al. 2009; Cunninghame Graham et al. 2011; Zhao et al. 2011;
Luo et al. 2011; So et al. 2011). Multiple GWAS have been conducted
for SLE in Eastern Asian populations, identifying 63 single-nucleotide
polymorphisms (SNPs) with genome-wide significant evidence (Zhang
et al. 2014; Yang et al. 2013; Li et al. 2013; Sheng et al. 2011, 2015;
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Han et al. 2009; Zhang et al. 2011; Yu et al. 2013; Sun et al. 2016).
Meanwhile,118 susceptibility SNPs have been established robustly in
the Caucasian populations (Graham et al. 2008; International Consor-
tium for Systemic Lupus Erythematosus et al. 2008; Kozyrev et al. 2008;
Hom et al. 2008; Gateva et al. 2009; Lessard et al. 2011; Chung et al.
2011; Cunninghame Graham et al. 2011; Fernando et al. 2012; Lessard
et al. 2012; Lee et al. 2012; Martin et al. 2013; Armstrong et al. 2014;
Kariuki et al. 2015; Vaughn et al. 2014; Demirci et al. 2016; Bentham
et al. 2015; Suarez-Gestal et al. 2009). These findings together promote
genetic etiology research for SLE. However, the mechanism underlying
each variant is still largely unknown. It is usually found that the variants
with robust association evidence in complex diseases GWAS are tag
SNPs that are linked to the true putative variants, rather than the
putative variant itself. In addition, the vast majority of these variants
reside in the noncoding genomic region, which therefore poses a great
challenge for interpretation and follow-up biological studies (Cui et al.
2013). Nevertheless, it is widely indicated that these variants contribute
to the risk of diseases mainly through regulating gene expression levels
by expression quantitative trait loci (eQTL) effects, or by changing
chromatin accessibility, rather altering protein function directly
(Edwards et al. 2013). In order to disentangle the functional role of
each variant in the disease, well-designed biological experiments are
warranted. It is strongly believed that each variant contributes to the
etiology of disease by affecting a typical tissue and cell through a
complicated biological pathway. Hence, in order to dissect the func-
tionality of each GWAS-identified variant, we have to use the most
relevant cells and tissues in biological experiments. Nowadays, there
are several integrative bioinformatics methods dedicated to identify-
ing the cell types, tissues, and pathways affected by GWAS-implicated
susceptibility variants (Weng et al. 2011). Some critical cells, tissues,
and pathways have been revealed for Crohn disease, rheumatoid
arthritis, and multiple sclerosis (Hu et al. 2011). Among them, Hu
et al.(2011) provided the evidence to underpin the key role of tran-
sitional B lymphocyte cells in the etiology of SLE.
In the present study, we employed a nonparameter enrichment
statistical approach to evaluate the specificity of conditions (i.e., cells,
tissues and pathways) in SLE (Slowikowski et al. 2014), and tested the
enrichment of eQTL sites and DNase I hypersensitivity sites (DHSs) in
SLE GWAS common variants.
MATERIALS AND METHODS
The studydesignandanalytical processarediagrammed inFigure1.The
enrichment test was implemented in SNPsea (Slowikowski et al. 2014).
We used 63 and 118 SNPs that had been reported previously with
genome-wide evidence in Eastern Asian and Caucasian populations,
respectively, as input (Supplemental Material, Table S1). It was noted
that 13 of the 118 SNPs from Caucasian populations reside in the
HLA region. In SNPsea, we identified genes implicated by each input
SNP using linkage disequilibrium (LD) information in the CHB
or CEU reference panel, respectively, from the 1000 Genomes Project.
To include all potential genes, we extended the SNP interval to the
nearest recombination hotspots with recombination rate . 3 cM/Mb
(HapMap 3) (Myers et al. 2005). If a SNP interval overlapped with no
gene intervals, we extended the SNP interval to 10,000 base pairs. If one
unified gene was implicated by at least two different SNPs, we merged
these SNPs into one single locus. Usually, multiple genes would be
implicated in each locus. But we assumed that there would be only
one single gene truly associated with SLE in each locus. We normalized
the expression of each gene through dividing its expression value in a
specific condition (i.e., the cell types, tissues, and pathways) by the L2
norm of gene expression values for that gene in all different conditions,
thus we would get an expression matrix with values between zero and
one, which was used to indicate the specificity of the gene to a condition.
For each condition, we ranked the normalized expression values in
descending order, and divided them by the number of implicated genes.
As a result, we got a score between zero and one, with smaller values
representing a higher specificity for a given condition (Hu et al. 2011).
We assigned the lowest score for each locus. For each condition, we
used a sampling approach to build a null SNP set, and then calculated
an empirical P-value through comparing its gene expression distribu-
tion with that of the SLE GWAS SNP set. This empirical P-value was
used to indicate the tail probability of observing a condition-specificity
score greater than, or equal to, the sum across all SNPs (Slowikowski
et al. 2014). The significance threshold was defined by Bonferroni
correction with the number of conditions used in each test. We applied
533 cell types expression matrix for Homo sapiens from FANTOM5
(Bonferroni P threshold = 0.05/533), 249 cell types expression
matrix for Mus musculus (GEO dataset: GSE15907, Bonferroni
P threshold = 0.05/249), 79 tissues expression matrix for H. sapiens
(Bonferroni P threshold = 0.05/79) (Su et al. 2004), and 1751 gene
expression ontology (GO) matrix (data-version: 2013-06-29, CVS re-
vision: 9700, Bonferroni P threshold = 0.05/1751), to test the specific-
ity of cell types, tissues and pathways, respectively.
The role of B lymphoblastoid cells in the pathogenesis of SLE is well
known. Our results in the SNPsea test also identified the significant
evidence of B lympholastoid cells in both Eastern Asian and Caucasian
populations. In addition, this test revealed themost significant evidence
for CD14+ monocytes in the pathophysiology of SLE. In an attempt to
unravel which functional part the SLE associated variant most likely
resides in, we incorporated the SLE GWAS summary statistics in Han
Chinese population, eQTL from B lymphoblastoid cells and DHSs
functional genomics data from CD14+ cells. We retrieved the GWAS
summary statistics for SLE described preciously in the Han Chinese
(Han et al. 2009). These contained the association evidence (single
variant P value) for 494,559 autosomal variants. The eQTL results for
whole blood B lymphocytes in 5311 Caucasian individuals were freely
accessed (Westra et al. 2013). In total, there were 923,021 and 4733
SNPs annotated to be cis-eQTL and trans-eQTL sites, respectively, in
whole blood B lymphocytes. The DHSs for CD14+ primary cells were
downloaded from the Encyclopedia of DNA Elements (ENCODE)
consortium database (accession: ENCFF001SRV), in which there
were 159,457 DHSs identified for CD14+ monocytes. Each of the
494,559 autosomal variants SNP in SLE GWAS was then annotated
by whether it resided in the DHSs in CD14+ monocytes, or the
eQTL site in whole blood B lymphocytes, respectively. The enrich-
ment of DHSs and eQTL effect were tested through genetic
analysis incorporating pleiotropy and annotation (GPA) packages
in R 3.12 (Chung et al. 2014). The enrichment size of DHS or
eQTL site was characterized by estimating the enrichment
fold (q1/q0), which was calculated as odds of proportional anno-
tated by CD14+ DHS, or whole blood lymphocytes, eQTL effect in
non-null- and null-associated SNPs (Chung et al. 2014). q1 and Q0
were defined as the probability of being annotated as DHS or
eQTL sites for non-null- and null-associated SNPs, respectively.
The statistical significance for the enrichment effect was evaluated
by likelihood ratio test. The maximum iteration was set to 10,000
in the GPA package.
Data availability
The authors state that all data necessary for confirming the conclusions
presented in the article are represented fully within the article.
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RESULTS
In Eastern Asian populations, it has been shown that the expression of
the implicated genes were significantly enriched in 19 types of cells, for
example, xeroderma pigentosum B cells (P = 1.00 · 1026), CD14+
monocytes (P = 7.33 · 1025), CD19+ B cells (P = 1.00 · 1026),
plasmacytoid dendritic cells (pDCs) (P = 9.00 · 1026), and
CD4+CD25+CD45RA–memory regulatory T cells (P = 2.20 · 1025)
(Figure 2A and Table S2). And significant evidence regarding B cells
(e.g., B.T1.sp, B.T2.sp, B.T3.sp, B.Fo.sp, B.MZ.Sp, B1a.sp, B.FrF.BM,
and B1a.pc etc.) was achieved consistently with using 249 cell types
expression matrix forMus musculus (P # 4.88 · 1025; Figure S1A
and Table S3). In peripheral blood, we achieved corrected significance
at CD19+ B cells (P = 1.00 · 1026), CD4+ T cells (P = 7.57 · 1025),
CD56+NK cells (P = 8.30 · 1025) (Figure 3A and Table S4). We
only observed GO:0002684 positive regulation of immune system pro-
cess (P = 1.60·10-5) was significantly elevated, although a series of the
immune response pathways achieved moderate significance (Figure
S2A and Table S5). In Caucasian populations, the cell enrichment test
also indicated that xeroderma pigentosum B cells (P = 1.00 · 1026),
CD14+monocytes (P = 1.00 · 1026), CD19+Bcells (P = 2.00 · 1026),
and plasmacytoid dendritic cells (pDCs) (P = 5.00 · 1026) were
significantly activated (Figure 2B and Table S2). Likewise, significant
evidence for B cells (e.g., B.T2.sp and B.T3.sp) was also achieved,
consistent with using 249 cell types expression matrix for Mus
musculus (P # 6.23 · 1025; Figure S1B and Table S3). In periph-
eral blood, we also discovered corrected significance at BDCA4+
dentritic cells (P = 3.00 · 1026) andCD56+NKcells (P = 3.62 · 1024)
(Figure 3B and Table S4). The GO pathway enrichment test showed
that 38 GO pathways relevant to immune process, cytokine pro-
duction and cell activation (P # 1.90 · 1025) were significantly
regulated (Figure S2B and Table S5).
In order to eliminate the possible influence of theHLA region on our
findings in Caucasian populations, we removed the 13 SNPs within the
HLA region, and conducted the condition enrichment analysis in the
SNPsea. Eventually, we achieved similar and consistent results to those
with the HLA region variants. The findings indicate that xeroderma
Figure 1 The study design and analytical process diagram. H.S., Homo sapiens; eQTL, expression quantitative trait locus; DHSs, DNase I
hypersensitive sites.
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Figure 2 The cell enrichment of SLE implicated genes, with 533 cell types expression matrix in H. sapiens. (A) Cell enrichment by 63 SNPs in an
Eastern Asian population. (B) Cell enrichment by 118 SNPs in a Caucasian population. The bottom indicates the log transformed P value. The
vertical line indicates the Bonferroni-corrected significance criteria (P # 9.38 · 1025). The cell types are listed on the right.
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pigentosum B cells (P = 1.00 · 1026), CD14+ monocytes
(P = 1.00 · 1026), CD19+ B cells (P = 1.00 · 1026), plasmacytoid
dendritic cells (pDCs) (P = 6.10 · 1025) remained significantly involved
in the SLE (Figure S3 andTable S2).Meanwhile, we achieved significant and
consistent evidence for B cells (e.g., B.T2.sp, B.T3.sp, CD19+ Control,
etc.) using 249 cell types expression matrix for Mus musculus
(P , 6.59 · 1025; Figure S1C andTable S3), and for BDCA4+dentritic
cells in peripheral blood (P = 1.00 · 1026; Figure S4 and Table S4).We
identified that the multiple immune response pathways remained signif-
icantly activated even without the HLA region (Figure 2SC and Table S5).
Figure 3 The tissue enrichment of SLE
implicated genes with 79 tissues expres-
sion matrix in H. sapiens. (A) Tissue enrich-
ment by 63 SNPs in an Eastern Asian
population. (B) Tissue enrichment by 118 SNPs
in a Caucasian population. The bottom indi-
cates the log transformed P value. The ver-
tical line indicated the Bonferroni-corrected
significance criteria (P # 6.33 · 1024). The
tissues names are listed in the right.
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In our SLE GWAS results in the Han Chinese population, of the
494,559 common variants, 110,893 and 16,981 SNPs were annotated as
eQTL site and DHS in human whole blood B lymphocytes and CD14+
monocytes, respectively. We observed a significant enrichment of
eQTL effect in the SLE GWAS association evidences (q1/q0 = 2.15,
P = 1.23 · 10244). And we found an enrichment effect of DHS in
CD14+ monocytes (q1/q0 = 1.41), and this effect achieved approxi-
mately nominal significance (P = 0.08).
DISCUSSION
In the past decades, the genetic susceptibility of SLE has been advanced
dramatically throughGWAS indiverse populations.However, the exact
mechanism for each individual variant is still unclear. In order to
ultimately dissect the mechanism, biological experiments must be
carefully conducted in the most relevant pathogenic cell types and
tissues. In the present study, we observed that several immune cells
(e.g., B cells, monocytes, and pDCs), and several immune regulating
signaling pathways, were significantly activated in the pathogenesis of
SLE in both Eastern Asian and Caucasian populations. Our findings
indicated that common SLE-associated genetic variants are more likely
to reside in eQTL sites and DHSs in whole blood B lymphocytes and
CD14+ monocytes, respectively. This result will help the identification
of SLE susceptibility variants in future studies.
SLE is a typical autoimmune disease. One of the remarkable hall-
marks of SLE is the generation of various immunological abnormalities
(Tsokos 2011). It is well accepted that B cells play an important role in
its mechanism (Chan et al. 1999). Our study underpins the critical role
of B cells, especially CD19+ B cells, in the etiology of SLE. In a pre-
liminary study, patients with SLE and secondary antiphospholipid syn-
drome (APS) showed depletion of CD3-CD19+ B cells, and their
decreasing number correlated with the severity of SLE (Dal Ben et al.
2014). Using the SLEGWAS summary statistics, we discovered that the
associated variants were significantly likely to confer an eQTL effect in
whole blood B cells. The results not only confirm the critical role of B
cells in the pathology of SLE, but also indicate that the genetic common
variants probably contribute to the risk of SLE, mainly by regulating
gene expression levels through eQTL effects. It has been broadly im-
plicated that GWAS findings in several common diseases are enriched
in eQTL sites (Nicolae et al. 2010). In addition, we revealed that the
expression level of SLE GWAS implicated genes was significantly
elevated in CD14+ monocytes. CD14+ monocytes have been demon-
strated to impair phagocytosis of autologous apoptotic polymorpho-
nuclear leukocytes (PMNs) (Mikolajczyk et al. 2014). Zhu et al. (2014)
detected a series of severe disease clinical manifestations and laboratory
features in SLE patients [e.g., presence of autoantibodies, 24-hr pro-
teinuria excretion or systemic lupus erythematosus disease activity
index (SLEDAI) $ 10] were associated with the decreased mAxl ex-
pression on CD14+ monocytes. Axl, which is responsible for clearance
of apoptotic cells and immune homeostasis maintenance, is a trans-
membrane receptor tyrosine kinase (RTK) expressed on the surface of
monocytes (mAxl) (Seitz et al. 2007). Our study revealed that SLE
GWAS association evidence was more likely to be enriched in the
DHSs in CD14+ monocytes. DHSs are considered as the mark of
transcriptionally active regions in the genome, and have cell specificity
(Thurman et al. 2012). The finding of enrichment of DHSs in GWAS
has been found in several other common diseases (Disanto et al. 2014;
Maurano et al. 2012; Handel et al. 2013; Chen et al. 2015). Additionally,
it is particularly noteworthy that we detected pDCs playing a pivotal
role in SLE. Studies using various experimental lupus models have
revealed that pDCs play an indispensable role in stimulating autoanti-
body response and facilitate lupus progression, which bolsters the
rationale of targeting pDCs to alleviating SLE (Baccala et al. 2013;
Sisirak et al. 2014; Rowland et al. 2014; Davison and Jorgensen
2015). Patients with SLE frequently have aberrant expression of genes
that are stimulated by type 1 interferons (IFN-a, IFN-b, IFN-v, IFN-t,
and IFN-I), a family of pluripotent cytokines that are important for
antiviral immune response, and this expression profile is correlated
with anti-dsDNA antibody levels and disease severity (Bennett et al.
2003; Banchereau and Pascual 2006). In SLE patients, pDCs are be-
lieved to be a major cellular source of IFN-I, primarily because they
readily produce IFN-I when exposed to SLE immune complexes or
other lupus-related, nucleic acid-containing compounds (Gilliet et al.
2008; Colonna et al. 2004; Reizis et al. 2011). In the present study, we
also detect that Treg cells and NK cells are moderately activated, and
confirm the role of these types of cells in the etiology of SLE. Regulatory
T (Treg) cells are a subset of CD4+ T cells (Ohl and Tenbrock 2014). So
far, it has been found that SLE may occur in connection with reduced
numbers or impaired function of circulating Treg cells (Ohl and
Tenbrock 2014). Only a minority of human CD4+ T cells expressing
the highest levels of CD25 (termed as CD4+CD25+ T cells) main-
tains self-tolerance by suppressing autoreactive lymphocytes (Ohl
and Tenbrock 2014). Seddiki et al. (2006) found that CD45RA+ cells
are members of the natural TREG lineage. To date, the literature has
disregardedNK cells as relevantmodulators in the pathogenesis of SLE,
and they are rarely observed in SLE, but show dysfunction in patients
with active SLE (Spada et al. 2015). Last, but not the least, it is notable
that the Xeroderma pigentosum (XP) B cell line has been revealed in
our study, although there is currently no evidence available linking XP
B cells with SLE. It is well known that XP is an autosomal recessive
disease, and shares the typical performance of solar sensitivity with SLE
patients (Tsokos 2011; Yang et al. 2015), which hence makes us believe
that one unique mechanism potentially accounts partially for these two
diseases. However, further studies are needed to elucidate the exact
mechanism. Recently, Sun et al. (2016) suggested that certain genes
implicated by SLE GWAS SNPs in Eastern Asian samples are signifi-
cantly expressed in multiple immune cell types (such as XP B cells,
CD19+ B cells, CD4+ T cells, and NK cells). In the present study, we
implicated these cells types in either Eastern Asian or Caucasian pop-
ulations. A comparison of the results suggests the important roles of
these cell types in the pathogenesis of SLE. Our study underpins the key
role of the immune regulating signaling pathways in the pathogenesis of
SLE. By analyzing 17 alleles attaining an extremely high bar of statistical
significance in the first round of GWAS, investigators demonstrated an
important role for several pathways contributing to SLE susceptibility,
including B-cell signaling and development, signaling through toll-like
receptors 7 and 9, and neutrophil function (Graham et al. 2009).
Although we found many similar results between Caucasian and
Eastern Asian populations, some differences were also observed. For
example, we detected spleen lymphocytes with villous lymphocytes cell
line (P = 4.27 · 1025) only in Eastern Asian populations. We spec-
ulate that this is caused by the relatively smaller number of GWAS
findings used in the Eastern Asian population, which leads to the
limited number of implicated genes in Eastern Asian populations in
our study, as well as ethnical heterogeneity because most of the gene
expression matrices used in our study come from Caucasian popula-
tions. We note that the role of spleen lymphocytes in SLE has become
well recognized. For example, Hu et al. (2011) tested the enrichment of
SLE-implicated genes within the 223 expression profiles, and revealed
transitional splenic B cells. The pathogenic nature of spleen lympho-
cytes is also supported by mouse models, and by demonstration of
the efficacious nature of spleen cells from lupus-prone MRL/lpr mice
targeted therapies (Huang et al. 2014; Fleischer et al. 2014).
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There are several weaknesses in our study. First, the condition
expression matrices used in our study are less comprehensive and lack
population, tissue and cell specificity. For example, the public data we
used to generate these results was mostly from Caucasian ancestry.
Second, the enrichment of DHSs in CD14+ monocytes did not achieve
significance. We assume this is due to the incomplete annotation of
DHSs in CD14+ cells. Third, the number of genes implicated with each
susceptibility variants relies on the LD information used in the SNPsea
algorithm. Thus, more complete LD information will help improve the
accuracy in future.
In summary, we implicated several immune cells and immune
systems in the pathogenesis of SLE. The findings will help guide the
design of future biological experiments for SLE.
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